Genomic structure of the KLK Locus

Characterization, regulation, and interactions within the protease web

Volumn , Issue , 2012, Pages 5-30

  Cretu, Daniela ^a   Yousef, George M ^b   Scorilas, Andreas ^c   Diamandis, Eleftherios P ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84912107241     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (120)

1. Anisowicz, A., Sotiropoulou, G., Stenman, G., Mok, S. C., and Sager, R. (1996). A novel protease homolog differentially expressed in breast and ovarian cancer. Mol. Med. 2, 624-636
2. Angermann, A., Bergmann, C., and Appelhans, H. (1989). Cloning and expression of human salivarygland kallikrein in Escherichia coli. Biochem. J. 262, 787-793
3. Ashley, P.L., and MacDonald, R.J. (1985). Tissue-specific expression of kallikrein-related genes in the rat. Biochemistry 24, 4520-4527
4. Baffa, R., Moreno, J.G., Monne, M., Veronese, M.L., and Gomella, L.G. (1996). A comparative analysis of prostate-specific antigen gene sequence in benign and malignant prostate tissue. Urology 47, 795-800
5. Baker, A.R., and Shine, J. (1985). Human kidney kallikrein: cDNA cloning and sequence analysis. DNA 4, 445-450
6. Batra J., Lose F., O'Mara T., Marquart L., Stephens C., Alexander K., Srinivasan S., Eeles R.A., Easton D.F., Al Olama A.A., Kote-Jarai Z., Guy M., Muir K., Lophatananon A., Rahman A.A., Neal D.E., Hamdy F.C., Donovan J.L., Chambers S., Gardiner R.A., Aitken J., Yaxley J., Kedda M.A., Clements J.A., and Spurdle A.B. (2011). Association between prostinogen (KLK15) genetic variants and prostate cancer risk and aggressiveness in Australia and a meta-analysis of GWAS data. PLoS One 6, e26527
7. Bayani, J., Paliouras, M., Planque, C., Shan, S.J., Graham, C., Squire, J.A., and Diamandis, E.P. (2008). Impact of cytogenetic and genomic aberrations of the kallikrein locus in ovarian cancer. Mol. Oncol. 2, 250-260
8. Bharaj, B., Scorilas, A., Giai, M., and Diamandis, E.P. (2000). TA repeat polymorphism of the 5a-reductase gene and breast cancer. Cancer Epidemiol. Biomarkers Prev. 9, 387-393
9. Bharaj, B.B., Luo, L.Y., Jung, K., Stephan, C., and Diamandis, E.P. (2002). Identification of single nucleotide polymorphisms in the human kallikrein 10 (KLK10) gene and their association with prostate, breast, testicular, and ovarian cancers. Prostate 51, 35-41
10. Bhoola, K.D., Figueroa, C.D., and Worthy, K. (1992). Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol. Rev. 44, 1-80
11. Boutanaev, A.M., Kalmykova, A.I., Shevelyov, Y.Y., and Nurminsky, D.I. (2002). Large clusters of co-expressed genes in the Drosophila genome. Nature 420, 666-669
12. Brookes, D.E., Zandvliet, D., Watt, F., Russell, P.J., and Molloy, P.L. (1998). Relative activity and specificity of promoters from prostate-expressed genes. Prostate 35, 18-26
13. Cedar, H. (1988). DNA methylation and gene activity. Cell 53, 3-4
14. Chan, H., Springman, E.B., and Clark, J.M. (1998). Expression and characterization of human tissue kallikrein variants. Protein Expr. Purif. 12, 361-370
15. Chang, A., Yousef, G.M., Jung, K., Rajpert-De Meyts, E., and Diamandis, E.P. (2001). Identification and molecular characterization of five novel kallikrein gene 13 (KLK13; KLK-L4) splice variants: differential expression in the human testis and testicular cancer. Anticancer Res. 21, 3147-3152
16. Chen, L.M., Murray, S.R., Chai, K.X., Chao, L., and Chao, J. (1994). Molecular cloning and characterization of a novel kallikrein transcript in colon and its distribution in human tissues. Braz. J. Med. Biol. Res. 27, 1829-1838
17. Clark, H.F., Gurney, A.L., Abaya, E., Baker, K., Baldwin, D., Brush, J., Chen, J., Chow, B., Chui, C., Crowley, C., Currell, B., Deuel, B., Dowd, P., Eaton, D., et al., and Gray, A. (2003). The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment. Genome Res. 13, 2265-2270
18. Cleutjens, K.B., van Eekelen, C.C., van der Korput, H.A., Brinkmann, A.O., and Trapman, J. (1996). Two androgen response regions cooperate in steroid hormone regulated activity of the prostate-specific antigen promoter. J. Biol. Chem. 271, 6379-6388
19. Cleutjens, K.B., van der Korput, H.A., van Eekelen, C.C., van Rooij, H.C., Faber, P.W., and Trapman, J. (1997). An androgen response element in a far upstream enhancer region is essential for high, androgen-regulated activity of the prostate-specific antigen promoter. Mol. Endocrinol. 11, 148-161
20. Cramer S.D., Chang B.L., Rao A., Hawkins G.A., Zheng S.L., Wade W.N., Cooke R.T., Thomas L.N., Bleecker E.R., Catalona W.J., Sterling D.A., Meyers D.A., Ohar J., and Xu J. (2003). Association between genetic polymorphisms in the prostate-specific antigen gene promoter and serum prostate-specific antigen levels. J. Natl. Cancer Inst. 95, 1044-1053
21. Das, H.K., Jackson, C.L., Miller, D.A., Leff, T., and Breslow, J.L. (1987). The human apolipoprotein C-II gene sequence contains a novel chromosome 19-specific minisatellite in its third intron. J. Biol. Chem. 262, 4787-4793
22. David, A., Mabjeesh, N., Azar, I., Biton, S., Engel, S., Bernstein, J., Romano, J., Avidor, Y., Waks, T., Eshhar, Z., Langer, S.Z., Lifschitz-Mercer, B., Matzkin, H., Rotman, G., Toporik, A., Savitsky, K., and Mintz, L. (2002). Unusual alternative splicing within the human kallikrein genes KLK2 and KLK3 gives rise to novel prostate-specific proteins. J. Biol. Chem. 277, 18084-19090
23. Davie, J.R., and Hendzel, M.J. (1994). Multiple functions of dynamic histone acetylation. J. Cell. Biochem. 55, 98-105
24. Diamandis, E.P., and Yousef, G.M. (2001). Human tissue kallikrein gene family: a rich source of novel disease biomarkers. Expert Rev. Mol. Diagn. 1, 182-190
25. Diamandis, E.P., and Yousef, G.M. (2002). Human tissue kallikreins: a family of new cancer biomarkers. Clin. Chem. 48, 1198-1205
26. Dong, Y., Kaushal, A., Brattsand, M., Nicklin, J., and Clements, J.A. (2003). Differential splicing of KLK5 and KLK7 in epithelial ovarian cancer produces novel variants with potential as cancer biomarkers. Clin. Cancer Res. 9, 1710-1720
27. Dong, Y., Bui, L.T., Odorico, D.M., Tan, O.L., Myers, S.A., Samaratunga, H., Gardiner, R.A., and Clements, J.A. (2005). Compartmentalized expression of kallikrein 4 (KLK4/hK4) isoforms in prostate cancer: nuclear, cytoplasmic and secreted forms. Endocr. Relat. Cancer 12, 875-889
28. Eden, S., Hashimshony, T., Keshet, I., Cedar, H., and Thorne, A.W. (1998). DNA methylation models histone acetylation. Nature 394, 842
29. Elliott, M.B., Irwin, D.M., and Diamandis, E.P. (2006). In silico identification and Bayesian phylogenetic analysis of multiple new mammalian kallikrein gene families. Genomics 88, 591-599
30. Emami, N., and Diamandis, E.P. (2007). New insights into the functional mechanisms and clinical applications of the kallikrein-related peptidase family. Mol. Oncol. 1, 269-287
31. Esteller, M., Hamilton, S.R., Burger, P.C., Baylin, S.B., and Herman, J.G. (1999). Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res. 59, 793-797
32. Evans, B.A., and Richards, R.I. (1985). Genes for the alpha and gamma subunits of mouse nerve growth factor are contiguous. EMBO J. 4, 133-138
33. Evans, B.A., Drinkwater, C.C., and Richards, R.I. (1987). Mouse glandular kallikrein genes. Structure and partial sequence analysis of the kallikrein gene locus. J. Biol. Chem. 262, 8027-8034
34. Fernando, S.C., Najar, F.Z., Guo, X., Zhou, L., Fu, Y., Geisert, R.D., Roe, B.A., and DeSilva, U. (2007). Porcine kallikrein gene family: genomic structure, mapping, and differential expression analysis. Genomics 89, 429-438
35. Forsgren, M., Raden, B., Israelsson, M., Larsson, K., and Heden, L.O. (1987). Molecular cloning and characterization of a full-length cDNA clone for human plasminogen. FEBS Lett. 213, 254-260
36. Fukushima, D., Kitamura, N., and Nakanishi, S. (1985). Nucleotide sequence of cloned cDNA for human pancreatic kallikrein. Biochemistry 24, 8037-8043
37. Gan, L., Lee, I., Smith, R., Argonza-Barrett, R., Lei, H., McCuaig, J., Moss, P., Paeper, B., and Wang, K. (2000). Sequencing and expression analysis of the serine protease gene cluster located in chromosome 19q13 region. Gene 257, 119-130
38. Goyal, J., Smith, K.M., Cowan, J.M., Wazer, D.E., Lee, S.W., and Band, V. (1998). The role for NES1 serine protease as a novel tumor suppressor. Cancer Res. 58, 4782-4786
39. Grimwood, J., Gordon, L.A., Olsen, A., Terry, A., Schmutz, J., Lamerdin, J., Hellsten, U., Goodstein, D., Couronne, O., Tran-Gyamfi, M., et al., and Lucas, S.M. (2004). The DNA sequence and biology of human chromosome 19. Nature 428, 529-535
40. Harvey, T.J., Hooper, J.D., Myers, S.A., Stephenson, S.A., Ashworth, L.K., and Clements, J.A. (2000). Tissue-specific expression patterns and fine mapping of the human kallikrein (KLK) locus on proximal 19q13.4. J. Biol. Chem. 48, 37397-37406
41. Heuze-Vourc'h, N., Leblond, V., and Courty, Y. (2003). Complex alternative splicing of the hKLK3 gene coding for the tumor marker PSA (prostate-specific-antigen). Eur. J. Biochem. 270, 706-714
42. Herman, J.G., Merlo, A., Mao, L., Lapidus, R.G., Issa, J.P., Davidson, N.E., Sidransky, D., and Baylin, S.B. (1995). Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res. 55, 4525-4530
43. Hermans, K.G., Bressers, A.A., van der Korput, H.A., Dits, N.F., Jenster, G., and Trapman, J. (2008). Two unique novel prostate-specific and androgen-regulated fusion partners of ETV4 in prostate cancer. Cancer Res. 68, 3094-3098
44. Hooper, J.D., Bui, L.T., Rae, F.K., Harvey, T.J., Myers, S.A., Ashworth, L.K., and Clements, J.A. (2001). Identification and characterization of KLK14, a novel kallikrein serine protease gene located on human chromosome 19q13.4 and expressed in prostate and skeletal muscle. Genomics 73, 117-122
45. Hu, J.C., Zhang, C., Sun, X., Yang, Y., Cao, X., Ryu, O., and Simmer, J.P. (2000). Characterization of the mouse and human PRSS17 genes, their relationship to other serine proteases, and the expression of PRSS17 in developing mouse incisors. Gene 251, 1-8
46. Huang, W., Shostak, Y., Tarr, P., Sawyers, C., and Carey, M. (1999). Cooperative assembly of androgen receptor into a nucleoprotein complex that regulates the prostate-specific antigen enhancer. J. Biol. Chem. 274, 25756-25768
47. Issa, J.P., Ottaviano, Y.L., Celano, P., Hamilton, S.R., Davidson, N.E., and Baylin, S.B. (1994). Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat. Genet. 7, 536-540
48. Kaushal, A., Myers, S.A., Dong, Y., Lai, J., Tan, O.L., Bui, L.T., Hunt, M.L., Digby, M.R., Samaratunga, H., Gardiner, R.A., Clements, J.A., and Hooper, J.D. (2008). A novel transcript from the KLKP1 gene is androgen regulated, down-regulated during prostate cancer progression and encodes the first non-serine protease identified from the human kallikrein gene locus. Prostate 68, 381-399
49. Komatsu, N., Takata, M., Otsuki, N., Toyama, T., Ohka, R., Takehara, K., and Saijoh, K. (2003). Expression and localization of tissue kallikrein mRNAs in human epidermis and appendages. J. Invest. Dermatol. 121, 542-549
50. Korkmaz, K.S., Korkmaz, C.G., Pretlow, T.G., and Saatcioglu, F. (2001). Distinctly different gene structure of KLK4/KLK-L1/prostase/ARM1 compared with other members of the kallikrein family: intracellular localization, alternative cDNA forms, and regulation by multiple hormones. DNA Cell Biol. 20, 435-445
51. Kramer, J.A., McCarrey, J.R., Djakiew, D., and Krawetz, S.A. (2000). Human spermatogenesis as a model to examine gene potentiation. Mol. Reprod. Dev. 56, 254-258
52. Krem, M.M., Rose, T., and Di Cera, E. (2000). Sequence determinants of function and evolution in serine proteases. Trends Cardiovasc. Med. 10, 171-176
53. Kurlender, L., Yousef, G.M., Memari, N., Robb, J.D., Michael, I.P., Borgoño, C., Katsaros, D., Stephan, C., Jung, K., and Diamandis, E.P. (2004). Differential expression of a human kallikrein 5 (KLK5) splice variant in ovarian and prostate cancer. Tumour Biol. 25, 149-156
54. Kurlender, L., Borgoño, C., Michael, I.P., Obiezu, C., Elliott, M.B., Yousef, G.M., and Diamandis, E.P. (2005). A survey of alternative transcripts of human tissue kallikrein genes. Biochim. Biophys. Acta 1755, 1-14
55. Lai, J., Myers, S.A., Lawrence, M.G., Odorico, D.M., and Clements, J.A. (2009). Direct progesterone receptor and indirect androgen receptor interactions with the kallikrein-related peptidase 4 gene promoter in breast and prostate cancer. Mol. Cancer Res. 7, 129-141
56. Lawrence, M.G., Lai, J., and Clements, J.A. (2010) Kallikreins on steroids: structure, function, and hormonal regulation of prostate-specific antigen and the extended kallikrein locus. Endocr. Rev. 31, 407-446
57. Li, B., Goyal, J., Dhar, S., Dimri, G., Evron, E., Sukumar, S., Wazer, D.E., and Band, V. (2001). CpG methylation as a basis for breast tumor-specific loss of NES1/kallikrein 10 expression. Cancer Res. 61, 8014-8021
58. Li, Q., Harju, S., and Peterson, K.R. (1999). Locus control regions: coming of age at a decade plus. Trends Genet. 15, 403-408
59. Li, X., Liu, J., Wang, Y., Zhang, L., Ning, L., and Feng, Y. (2009). Parallel underexpression of kallikrein 5 and kallikrein 7 mRNA in breast malignancies. Cancer Sci. 100, 601-607
60. Little, S.P., Dixon, E.P., Norris, F., Buckley, W., Becker, G.W., Johnson, M., Dobbins, J. R., Wyrick, T., Miller, J.R., MacKellar, W., Hepburn, D., Corvalan, J., McClure, D., Liu, X., Stephenson, D., Clemens, J., and Johnstone, E.M. (1997). Zyme, a novel and potentially amyloidogenic enzyme cDNA isolated from Alzheimer's disease brain. J. Biol. Chem. 272, 25135-25142
61. Liu, X.F., Essand, M., Vasmatzis, G., Lee, B., and Pastan, I. (1999). Identification of three new alternate human kallikrein 2 transcripts: evidence of long transcript and alternative splicing. Biochem. Biophys. Res. Commun. 264, 833-839
62. Liu, X.L., Wazer, D.E., Watanabe, K., and Band, V. (1996). Identification of a novel serine proteaselike gene, the expression of which is down-regulated during breast cancer progression. Cancer Res. 56, 3371-3379
63. Lu, J., Goldstein, K.M., Chen, P., Huang, S., Gelbert, L.M., and Nagpal, S. (2005). Transcriptional profiling of keratinocytes reveals a vitamin D-regulated epidermal differentiation network. J. Invest. Dermatol. 124, 778-785
64. Lu, W., Zhou, D., Glusman, G., Utleg, A.G., White, J.T., Nelson, P.S., Vasicek, T.J., Hood, L., and Lin, B. (2006). KLK31P is a novel androgen regulated and transcribed pseudogene of kallikreins that is expressed at lower levels in prostate cancer cells than in normal prostate cells. Prostate 66, 936-944
65. Luo, L., Herbrick, J.A., Scherer, S.W., Beatty, B., Squire, J., and Diamandis, E.P. (1998). Structural characterization and mapping of the normal epithelial cell-specific 1 gene. Biochem. Biophys. Res. Commun. 247, 580-586
66. Lundwall, A. (1989). Characterization of the gene for prostate-specific antigen, a human glandular kallikrein. Biochem. Biophys. Res. Commun. 161, 1151-1159
67. Lundwall, A., Band, V., Blaber, M., Clements, J.A., Courty, Y., Diamandis, E.P., Fritz, H., Lilja, H., Malm, J., Maltais, L.J., Olsson, A.Y., Petraki, C., Scorilas, A., Sotiropoulou, G., Stenman, U.H., Stephan, C., Talieri, M., and Yousef, G.M. (2006a). A comprehensive nomenclature for serine proteases with homology to tissue kallikreins. Biol. Chem. 387, 637-641
68. Lundwall, A., Clauss, A., and Olsson, A.Y. (2006b). Evolution of kallikrein-related peptidases in mammals and identification of a genetic locus encoding potential regulatory inhibitors. Biol. Chem. 387, 243-249
69. MacDonald, R.J., Southard-Smith, E.M., and Kroon, E. (1996). Disparate tissue-specific expression of members of the tissue kallikrein multigene family of the rat. J. Biol. Chem. 271, 13684-13690
70. Majumdar, S., and Diamandis, E.P. (1999). The promoter and the enhancer region of the KLK 3 (prostate specific antigen) gene is frequently mutated in breast tumours and in breast carcinoma cell lines. Br. J. Cancer 79, 1594-1602
71. Magklara, A., Scorilas, A., Katsaros, D., Massobrio, M., Yousef, G.M., Fracchioli, S., Danese, S., and Diamandis, E.P. (2001). The human KLK8 (neuropsin/ovasin) gene: identification of two novel splice variants and its prognostic value in ovarian cancer. Clin. Cancer Res. 7, 806-811
72. Mason, A.J., Evans, B.A., Cox, D.R., Shine, J., and Richards, R.I. (1983). Structure of mouse kallikrein gene family suggests a role in specific processing of biologically active peptides. Nature 303, 300-307
73. Mavridis, K., Avgeris, M., Koutalellis, G., Stravodimos, K., and Scorilas, A. (2010). Expression analysis and study of the KLK15 mRNA splice variants in prostate cancer and benign prostatic hyperplasia. Cancer Sci. 101, 693-699
74. Meyer, W. (2001). Distribution of tissue kallikrein in the integumental blood vessel system of wild mammals. Cell. Mol. Biol. (Noisy-le-grand) 47 Online Pub, OL125-130
75. Michael, I.P., Kurlender, L., Memari, N., Yousef, G.M., Du, D., Grass, L., Stephan, C., Jung, K., and Diamandis, E.P. (2005). Intron retention: a common splicing event within the human kallikrein gene family. Clin. Chem. 51, 506-515
76. Mitsui, S., Tsuruoka, N., Yamashiro, K., Nakazato, H., and Yamaguchi, N. (1999). A novel form of human neuropsin, a brain-related serine protease, is generated by alternative splicing and is expressed preferentially in human adult brain. Eur. J. Biochem. 260, 627-634
77. Murtha, P., Tindall, D.J., and Young, C.Y. (1993). Androgen induction of a human prostate-specific kallikrein, hKLK2: characterization of an androgen response element in the 5' promoter region of the gene. Biochemistry 32, 6459-6464
78. Nakayama, S., Sasaki, A., Mese, H., Alcalde, R.E., Tsuji, T., and Matsumura, T. (2001). The E-cadherin gene is silenced by CpG methylation in human oral squamous cell carcinomas. Int. J. Cancer 93, 667-673
79. Nelson, P.S., Gan, L., Ferguson, C., Moss, P., Gelinas, R., Hood, L., and Wang, K. (1999). Molecular cloning and characterization of prostase, an androgen-regulated serine protease with prostaterestricted expression. Proc. Natl. Acad. Sci. USA 96, 3114-3119
80. Ni, X., Zhang, W., Huang, K.C., Wang, Y., Ng, S.K., Mok, S.C., Berkowitz, R.S., and Ng, S.W. (2004). Characterisation of human kallikrein 6/protease M expression in ovarian cancer. Br. J. Cancer 91, 725-731
81. Obiezu C.V., and Diamandis E.P. (2000). An alternatively spliced variant of KLK4 expressed in prostatic tissue. Clin. Biochem. 33, 599-600
82. Olsson, A. Y., and Lundwall, A. (2002). Organization and evolution of the glandular kallikrein locus in Mus musculus. Biochem. Biophys. Res. Commun. 299, 305-311
83. Olsson, A.Y., Valtonen-Andre, C., Lilja, H., and Lundwall, A. (2004). The evolution of the glandular kallikrein locus: identification of orthologs and pseudogenes in the cotton-top tamarin. Gene 343, 347-355
84. Pampalakis, G., Kurlender, L., Diamandis, E.P., and Sotiropoulou, G. (2004). Cloning and characterization of novel isoforms of the human kallikrein 6 gene. Biochem. Biophys. Res. Commun. 320, 54-61
85. Pampalakis, G., Diamandis, E.P., and Sotiropoulou, G. (2006). The epigenetic basis for the aberrant expression of kallikreins in human cancers. Biol. Chem. 387, 795-799
86. Planque, C., Choi, Y.H., Guyetant, S., Heuzé-Vourc'h, N., Briollais, L., and Courty, Y. (2010). Alternative splicing variant of kallikrein-related peptidase 8 as an independent predictor of unfavorable prognosis in lung cancer. Clin. Chem. 56, 987-997
87. Rae, F., Bulmer, B., Nicol, D., and Clements, J. (1999). The human tissue kallikreins (KLKs 1-3) and a novel KLK1 mRNA transcript are expressed in a renal cell carcinoma cDNA library. Immunopharmacology 45, 83-88
88. Riegman, P.H., Vlietstra, R.J., Klaassen, P., van der Korput, J.A., Geurts van Kessel, A., Romijn, J.C., and Trapman, J. (1989a). The prostate-specific antigen gene and the human glandular kallikrein-1 gene are tandemly located on chromosome 19. FEBS Lett. 247, 123-126
89. Riegman, P.H., Vlietstra, R.J., van der Korput, J.A., Romijn, J.C., and Trapman, J. (1989b). Characterization of the prostate-specific antigen gene: a novel human kallikrein-like gene. Biochem. Biophys. Res. Commun. 159, 95-9102
90. Riegman, P.H., Vlietstra, R.J., van der Korput, H.A., Romijn, J.C., and Trapman, J. (1991). Identification and androgen-regulated expression of two major human glandular kallikrein-1 (hGK-1) mRNA species. Mol. Cell. Endocrinol. 76, 181-190
91. Riegman, P.H., Vlietstra, R.J., Suurmeijer, L., Cleutjens, C.B., and Trapman, J. (1992). Characterization of the human kallikrein locus. Genomics 14, 6-11
92. Roman-Gomez, J., Jimenez-Velasco, A., Agirre, X., Castillejo, J.A., Barrios, M., Andreu, E.J., Prosper, F., Heiniger, A., and Torres, A. (2004). The normal epithelial cell-specific 1 (NES1) gene, a candidate tumor suppressor gene on chromosome 19q13.3-4, is downregulated by hypermethylation in acute lymphoblastic leukemia. Leukemia 18, 362-365
93. Sauter, E.R., Welch, T., Magklara, A., Klein, G., and Diamandis, E.P. (2002). Ethnic variation in kallikrein expression in nipple aspirate fluid. Int. J. Cancer 100, 678-682
94. Schedlich, L.J., Bennetts, B.H., and Morris, B.J. (1987). Primary structure of a human glandular kallikrein gene. DNA 6, 429-437
95. Scheidereit, C., Geisse, S., Westphal, H.M., and Beato, M. (1983). The glucocorticoid receptor binds to defined nucleotide sequences near the promoter of mouse mammary tumour virus. Nature 304, 749-752
96. Shinoda, Y., Kozaki, K., Imoto, I., Obara, W., Tsuda, H., Mizutani, Y., Shuin, T., Fujioka, T., Miki, T., and Inazawa, J. (2007). Association of KLK5 overexpression with invasiveness of urinary bladder carcinoma cells. Cancer Sci. 98, 1078-1086
97. Southard-Smith, M., Pierce, J.C., and MacDonald, R.J. (1994). Physical mapping of the rat tissue kallikrein family in two gene clusters by analysis of P1 bacteriophage clones. Genomics 22, 404-417
98. Stallmach, A., Wittig, B.M., Kremp, K., Goebel, R., Santourlidis, S., Zeitz, M., Menges, M., Raedle, J., Zeuzem, S., and Schulz, W.A. (2003). Downregulation of CD44v6 in colorectal carcinomas is associated with hypermethylation of the CD44 promoter region. Exp. Mol. Pathol. 74, 262-266
99. Stephenson, S.A., Verity, K., Ashworth, L.K., and Clements, J.A. (1999). Localization of a new prostate-specific antigen-related serine protease gene, KLK4, is evidence for an expanded human kallikrein gene family cluster on chromosome 19q13.3-13.4. J. Biol. Chem. 274, 23210-23214
100. Strausberg, R.L., Feingold, E.A., Grouse, L.H., Derge, J.G., Klausner, R.D., Collins, F. S., Wagner, L., Shenmen, C.M., Schuler, G.D., Altschul, S.F., Zeeberg, B., Buetow, K. H., Schaefer, C.F., Bhat, N.K., et al., and Marra, M.A. (2002). Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proc. Natl. Acad. Sci. U.S.A. 99, 16899-16903
101. Tanaka, T., Isono, T., Yoshiki, T., Yuasa, T., and Okada, Y. (2000). A novel form of prostate-specific antigen transcript produced by alternative splicing. Cancer Res. 60, 56-59
102. van Leeuwen, B.H., Evans, B.A., Tregear, G.W., and Richards, R.I. (1986). Mouse glandular kallikrein genes. Identification, structure, and expression of the renal kallikrein gene. J. Biol. Chem. 261, 5529-5535
103. Vermaak, D., and Wolffe, A.P. (1998). Chromatin and chromosomal controls in development. Dev. Genet. 22, 1-6
104. Wei, C., Callahan, B.P., Turner, M.J., Willis, R.A., Lord, E.M., Barth, R.K., and Frelinger, J.G. (1998). Regulation of human prostate-specific antigen gene expression in transgenic mice: evidence for an enhancer between the PSA and human glandular kallikrein-1 genes. Int. J. Mol. Med. 2, 487-496
105. Yamashiro, K., Tsuruoka, N., Kodama, S., Tsujimoto, M., Yamamura, Y., Tanaka, T., Nakazato, H., and Yamaguchi, N. (1997). Molecular cloning of a novel trypsin-like serine protease (neurosin) preferentially expressed in brain. Biochim. Biophys. Acta 1350, 11-14
106. Yoshida, S., Taniguchi, M., Hirata, A., and Shiosaka, S. (1998). Sequence analysis and expression of human neuropsin cDNA and gene. Gene 213, 9-16
107. Yousef, G.M., and Diamandis, E.P. (1999). The new kallikrein-like gene, KLK-L2. Molecular characterization, mapping, tissue expression, and hormonal regulation. J. Biol. Chem. 274, 37511-375116
108. Yousef, G.M., Obiezu, C.V., Luo, L.Y., Black, M.H., and Diamandis, E.P. (1999). Prostase/KLK-L1 is a new member of the human kallikrein gene family, is expressed in prostate and breast tissues, and is hormonally regulated. Cancer Res. 59, 4252-4256
109. Yousef, G.M., Chang, A., Scorilas, A., and Diamandis, E.P. (2000). Genomic organization of the human kallikrein gene family on chromosome 19q13.3-q13.4. Biochem. Biophys. Res. Commun. 276, 125-133
110. Yousef, G.M., and Diamandis, E.P. (2001). The new human tissue kallikrein gene family: structure, function, and association to disease. Endocr. Rev. 22, 184-204
111. Yousef, G.M., Bharaj, B.S., Yu, H., Poulopoulos, J., and Diamandis, E.P. (2001). Sequence analysis of the human kallikrein gene locus identifies a unique polymorphic minisatellite element. Biochem. Biophys. Res. Commun. 285, 1321-1329
112. Yousef, G.M., Ordon, M.H., Foussias, G., and Diamandis, E.P. (2002). Genomic organization of the siglec gene locus on chromosome 19q13.4 and cloning of two new siglec pseudogenes. Gene 286, 259-270
113. Yousef, G.M., and Diamandis, E.P. (2003). An overview of the kallikrein gene families in humans and other species: emerging candidate tumour markers. Clin. Biochem. 36, 443-452
114. Yousef, G.M., Kopolovic, A.D., Elliott, M.B., and Diamandis, E.P. (2003a). Genomic overview of serine proteases. Biochem. Biophys. Res. Commun. 305, 28-36
115. Yousef, G.M., Polymeris, M.E., Yacoub, G.M., Scorilas, A., Soosaipillai, A., Popalis, C., Fracchioli, S., Katsaros, D., and Diamandis, E.P. (2003b). Parallel overexpression of seven kallikrein genes in ovarian cancer. Cancer Res. 63, 2223-2227
116. Yousef, G.M., White, N.M., Kurlender, L., Michael, I., Memari, N., Robb, J.D., Katsaros, D., Stephan, C., Jung, K., and Diamandis, E.P. (2004a). The kallikrein gene 5 splice variant 2 is a new biomarker for breast and ovarian cancer. Tumour Biol. 25, 221-227
117. Yousef, G.M., Elliott, M.B., Kopolovic, A.D., Serry, E., and Diamandis, E.P. (2004b). Sequence and evolutionary analysis of the human trypsin subfamily of serine peptidases. Biochim. Biophys. Acta 1698, 77-86
118. Yu, D.C., Sakamoto, G.T., and Henderson, D.R. (1999). Identification of the transcriptional regulatory sequences of human kallikrein 2 and their use in the construction of calydon virus 764, an attenuated replication competent adenovirus for prostate cancer therapy. Cancer Res. 59, 1498-1504
119. Yu, H., Bowden, D.W., Spray, B.J., Rich, S.S., and Freedman, B.I. (1998). Identification of human plasma kallikrein gene polymorphisms and evaluation of their role in end-stage renal disease. Hypertension 31, 906-911
120. Zeng, M., Zhang, Y., Bhat, I., Wazer, D.E., Band, H., and Band, V. (2006). The human kallikrein 10 promoter contains a functional retinoid response element. Biol. Chem. 387, 741-747